Variant report
Variant | nsv998916 |
---|---|
Chromosome Location | chr2:186181992-186217685 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:186182448..186185032-chr9:101737617..101739647,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555076054 | chr2:186182044-186182045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577554094 | chr2:186182074-186182075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114494841 | chr2:186182112-186182113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs367653589 | chr2:186182146-186182147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183146474 | chr2:186182183-186182184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572338239 | chr2:186182231-186182232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542967910 | chr2:186182244-186182245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs13033166 | chr2:186182262-186182263 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs531545452 | chr2:186182263-186182264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377201758 | chr2:186182279-186182280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs77122587 | chr2:186182283-186182284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11308643 | chr2:186182299-186182300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375922862 | chr2:186182306-186182307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577451609 | chr2:186182343-186182344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544821041 | chr2:186182351-186182352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370002272 | chr2:186182367-186182368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532380107 | chr2:186182375-186182376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547803942 | chr2:186182376-186182377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565749707 | chr2:186182383-186182384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536518880 | chr2:186182386-186182387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187598662 | chr2:186182435-186182436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569873206 | chr2:186182478-186182479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563217035 | chr2:186182505-186182506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555980198 | chr2:186182522-186182523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530719596 | chr2:186182523-186182524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs117120598 | chr2:186182524-186182525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs193021447 | chr2:186182529-186182530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs112994346 | chr2:186182540-186182541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368416383 | chr2:186182559-186182560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549319317 | chr2:186182561-186182562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542904548 | chr2:186182602-186182603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554944993 | chr2:186182640-186182641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs371885022 | chr2:186182642-186182643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372323772 | chr2:186182767-186182768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375569925 | chr2:186182829-186182830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576301254 | chr2:186182904-186182905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146124707 | chr2:186182935-186182936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561167210 | chr2:186182950-186182951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528585364 | chr2:186182965-186182966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs369317048 | chr2:186182967-186182968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532604448 | chr2:186182992-186182993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12989637 | chr2:186183016-186183017 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs571783987 | chr2:186183074-186183075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs559273589 | chr2:186183083-186183084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs62198771 | chr2:186183130-186183131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530044192 | chr2:186183152-186183153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527954998 | chr2:186183154-186183155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189028242 | chr2:186183188-186183189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs34212416 | chr2:186183191-186183192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs377241876 | chr2:186183200-186183201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Autism | 22543975 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:186182000-186183400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
2 | chr2:186182200-186182600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr2:186182200-186183000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr2:186182200-186183400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr2:186182400-186182800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr2:186182400-186183000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
7 | chr2:186182400-186183400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr2:186183000-186183800 | Enhancers | HepG2 | liver |
9 | chr2:186191400-186191800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr2:186196800-186197200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr2:186196800-186197200 | ZNF genes & repeats | Aorta | Aorta |
12 | chr2:186196800-186197200 | ZNF genes & repeats | Gastric | stomach |
13 | chr2:186196800-186197200 | ZNF genes & repeats | Pancreas | Pancrea |
14 | chr2:186200400-186201400 | Enhancers | Muscle Satellite Cultured Cells | -- |
15 | chr2:186202200-186203600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
16 | chr2:186202600-186203600 | Enhancers | HMEC | breast |
17 | chr2:186203600-186207400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |